Implications of Lipids in Neonatal Body Weight and Fat Mass in Gestational Diabetic Mothers and Non-Diabetic Controls
Abstract
Purpose of review Maternal lipid metabolism greatly changes during pregnancy and we review in this article how they influence fetal adiposity and growth under non-diabetic and gestational diabetic conditions. Recent findings In pregnant women without diabetes (control), maternal glycemia correlates with neonatal glycemia, neonatal body weight and fat mass. In pregnant women with gestational diabetes mellitus (GDM), maternal glucose correlates with neither neonatal glycemia, neonatal birth weight nor fat mass, but maternal triacylglycerols (TAG), non-esterified fatty acids (NEFA) and glycerol do correlate with birth weight and neonatal adiposity. The proportions of maternal plasma arachidonic (AA) and docosahexaenoic (DHA) acids decrease from the first to the third trimester of pregnancy, and at term these long-chain polyunsaturated fatty acids are higher in cord blood plasma than in mothers, indicating efficient placental transfer. In control or pregnant women with GDM at term, the maternal concentration of individual fatty acids does not correlate with neonatal body weight or fat mass, but cord blood fatty acid levels correlate with birth weight and neonatal adiposity-positively in controls, but negatively in GDM. The proportion of AA and DHA in umbilical artery plasma in GDM is lower than in controls but not in umbilical vein plasma. Therefore, an increased utilization of those two fatty acids by fetal tissues, rather than impaired placental transfer, is responsible for their smaller proportion in plasma of GDM newborns. In control pregnant women, maternal glycemia controls neonatal body weight and fat mass, whereas in mothers with GDM-even with good glycemic control-maternal lipids and their greater utilization by the fetus play a critical role in neonatal body weight and fat mass. We propose that altered lipid metabolism rather than hyperglycemia constitutes a risk for macrosomia in GDM.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
Women with GDM exhibit lower proportions of AA and DHA in maternal umbilical arteries compared to controls.
“Women with GDM exhibit lower proportions of AA and DHA in maternal umbilical arteries compared to controls, suggesting increased foetal utilisation of LCPUFA [102,103].”
From Medical Nutrition Therapy for Women with Gestational Diabetes: Current Practice and Future Perspectives (2025) · cites this paper as [103]
Cord blood omega-6 LCPUFA levels inversely correlate with neonatal birth weight in GDM-complicated pregnancies, unlike in controls.
“Cord blood omega-6 LCPUFA levels also inversely correlate with neonatal birth weight in GDM-complicated pregnancies, unlike in controls [103].”
From Medical Nutrition Therapy for Women with Gestational Diabetes: Current Practice and Future Perspectives (2025) · cites this paper as [103]
Cites
Hyperglycemia and adverse pregnancy outcomes
(2008) · New England Journal of Medicine · doi:10.1056/nejmoa0707943 · Cited by 5,563 · see citing works
Buchanan, T. A., & Xiang, A. H. (2005) · Journal of Clinical Investigation · doi:10.1172/jci200524531 · Cited by 2,123 · see citing works
Cellular Mechanisms for Insulin Resistance in Normal Pregnancy and Gestational Diabetes
Barbour, L. A., McCurdy, C. E., Hernandez, T. L., Kirwan, J. P., Catalano, P. M., & Friedman, J. E. (2007) · Diabetes Care · doi:10.2337/dc07-s202 · Cited by 811 · see citing works
Hyperglycemia and Adverse Pregnancy Outcome (HAPO) Study
The HAPO Study Cooperative Research Group (2009) · Diabetes · doi:10.2337/db08-1112 · Cited by 702 · see citing works
Schaefer-Graf, U. M., Graf, K., Kulbacka, I., Kjos, S. L., Dudenhausen, J., Vetter, K., & Herrera, E. (2008) · Diabetes Care · doi:10.2337/dc08-0039 · Cited by 439 · see citing works
Self-citationPrevalence of gestational diabetes mellitus in Europe: A meta-analysis
Eades, C. E., Cameron, D. M., & Evans, J. M. M. (2017) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2017.03.030 · Cited by 300 · see citing works
Mills, J. L., Jovanovic, L., Knopp, R., Aarons, J., Conley, M., Park, E., Lee, Y. J., Holmes, L., Simpson, J. L., & Metzger, B. (1998) · Metabolism · doi:10.1016/s0026-0495(98)90290-6 · Cited by 199 · see citing works
Hyperinsulinemia and Macrosomia in the Fetus of the Diabetic Mother
Schwartz, R., Gruppuso, P. A., Petzold, K., Brambilla, D., Hiilesmaa, V., & Teramo, K. A. (1994) · Diabetes Care · doi:10.2337/diacare.17.7.640 · Cited by 193 · see citing works
Radaelli, T., Lepercq, J., Varastehpour, A., Basu, S., Catalano, P. M., & Hauguel-De Mouzon, S. (2009) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2009.04.019 · Cited by 156 · see citing works
Ortega-Senovilla, H., Alvino, G., Taricco, E., Cetin, I., & Herrera, E. (2009) · Diabetes Care · doi:10.2337/dc08-0679 · Cited by 77 · see citing works
Self-citationThe Role of Adipokines in Gestational Diabetes Mellitus
Al-Badri, M. R., Zantout, M. S., & Azar, S. T. (2015) · Therapeutic Advances in Endocrinology and Metabolism · doi:10.1177/2042018815577039 · Cited by 71 · see citing works
Prevalence of gestational diabetes mellitus according to IADPSG and NICE criteria
Djelmis, J., Pavić, M., Mulliqi Kotori, V., Pavlić Renar, I., Ivanisevic, M., & Oreskovic, S. (2016) · International Journal of Gynecology & Obstetrics · doi:10.1016/j.ijgo.2016.07.005 · Cited by 53 · see citing works
Flagged first, then by citations
Cited by
Sorted by citations
Cheong, L., Law, L. S.-C., Tan, L. Y. L., Amal, A. A.-A., Khoo, C. M., & Eng, P. C. (2025) · Nutrients · doi:10.3390/nu17071210 · Cited by 14 · see citing works
- Authors
- Herrera, E., & Ortega-Senovilla, H.
- Venue
- Current Diabetes Reports
- Published
- 2018-02
- Volume
- 18
- Issue
- 2
- Pages
- 7-7
- ISSN
- 1534-4827 (ISSN-L)
- 1539-0829
- OpenAlex
- W2789642184
- Cited by
- 68
- References
- 12
- Citations by year
- 2026: 4 · 2025: 3 · 2024: 6 · 2023: 2 · 2022: 10 · 2021: 26 · 2020: 10 · 2019: 7
- FWCI
- 1.74
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Current Diabetes Reports (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Fundación Ramón Areces
- Ministerio de Economía y Competitividad
- Topics
- Health Sciences › Medicine › Obstetrics and Gynecology › Gestational Diabetes Research and Management
- Health Sciences › Medicine › Pediatrics, Perinatology and Child Health › Birth, Development, and Health
- Health Sciences › Nursing › Nutrition and Dietetics › Fatty Acid Research and Health
- Keywords
- gestational diabetes mellitus, neonatal body weight, neonatal fat mass, fetal adiposity, maternal lipid metabolism, triglycerides, free fatty acids, glycerol, arachidonic acid, docosahexaenoic acid, long-chain polyunsaturated fatty acids, placental transfer, umbilical cord blood, macrosomia, maternal glycemia
- MeSH terms
- Birth Weight, Female, Humans, Infant, Newborn, Lipids, Mothers, Pregnancy, Case-Control Studies, Diabetes, Gestational, Adiposity, Lipid Metabolism
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review